Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Paycor HCM (PYCR – Research Report), Monte Rosa Therapeutics (GLUE – Research Report) and Hologic (HOLX – Research Report).
Paycor HCM (PYCR)
J.P. Morgan analyst Mark Murphy maintained a Hold rating on Paycor HCM on November 9 and set a price target of $22.00. The company’s shares closed last Monday at $19.61.
According to TipRanks.com, Murphy is a 5-star analyst with an average return of
Paycor HCM has an analyst consensus of Moderate Buy, with a price target consensus of $26.53, a 40.5% upside from current levels. In a report issued on November 7, UBS also initiated coverage with a Hold rating on the stock with a $20.00 price target.
See the top stocks recommended by analysts >>
Monte Rosa Therapeutics (GLUE)
J.P. Morgan analyst Eric Joseph maintained a Buy rating on Monte Rosa Therapeutics on November 9 and set a price target of $10.00. The company’s shares closed last Monday at $3.06, close to its 52-week low of $2.44.
According to TipRanks.com, Joseph is a 2-star analyst with an average return of
The word on The Street in general, suggests a Strong Buy analyst consensus rating for Monte Rosa Therapeutics with a $11.00 average price target, which is a 243.8% upside from current levels. In a report issued on November 9, TD Cowen also maintained a Buy rating on the stock.
Hologic (HOLX)
In a report issued on November 10, Casey Woodring from J.P. Morgan maintained a Buy rating on Hologic, with a price target of $85.00. The company’s shares closed last Monday at $71.40.
According to TipRanks.com, Woodring has currently 0 stars on a ranking scale of 0-5 stars, with an average return of
The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Hologic with a $80.50 average price target, representing an 11.6% upside. In a report issued on October 26, Needham also maintained a Buy rating on the stock with a $83.00 price target.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Read More on PYCR:
